Hepatitis C virus

Monica Jarrett1, Paula Cox

  • 1Hepatology Department, University of Washington, 1959 NE Pacific Street, Box 357266, Seattle, WA 98195-7266, USA. jarrett@u.washington.edu

Insights

Hepatitis C virus (HCV) infections are declining, but long-term liver damage is emerging in previously infected individuals. Early identification and supervised treatment are crucial for managing advanced liver disease.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Public Health

Background:

  • Hepatitis C virus (HCV) is a prevalent blood-borne pathogen with declining new infections.
  • Individuals infected 2-3 decades ago are now presenting with significant liver damage.
  • HCV-related liver disease poses a growing clinical challenge.

Purpose of the Study:

  • To highlight the delayed onset of liver damage in chronic Hepatitis C virus patients.
  • To emphasize the importance of current treatment options and management strategies.
  • To advocate for improved identification and screening of at-risk populations.

Main Methods:

  • Review of existing literature on Hepatitis C virus epidemiology and long-term sequelae.
  • Analysis of treatment protocols involving interferon (IFN) and ribavirin.
  • Discussion of multidisciplinary care models involving nurses, physicians, and pharmacists.
  • Assessment of educational outreach strategies for public and healthcare provider awareness.

Main Results:

  • Chronic HCV infection leads to liver damage years after initial infection.
  • Interferon (IFN) and ribavirin treatment is effective but requires close monitoring due to adverse events.
  • Multidisciplinary supervision over 6-12 months is necessary for optimal patient outcomes.
  • Educational initiatives can improve early patient detection and screening.

Conclusions:

  • Despite declining incidence, managing established liver damage from past Hepatitis C virus infections is critical.
  • Supervised, prolonged treatment regimens are essential for patients with advanced liver disease.
  • Enhanced public and provider education is vital for early identification and screening of high-risk groups to mitigate HCV complications.

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Subviral Agents01:29

Subviral Agents

Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...